Lupin, Zentiva ink deal to commercialize biosimilar certolizumab
The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, plaque psoriasis and Crohn’s disease.